About: Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 April 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2019 (uk) artículu científicu espublizáu n'abril de 2019 (ast) im April 2019 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 17 April 2019 (en)
publication date	wds:Q64106171-DF47155F-6C51-4D8A-ADDB-1101E2B9E9F5
publication date	2019-04-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64106171-D9CDB5D1-27C7-427B-9441-5B911328E52A
language of work or name	English
cites work	wds:Q64106171-2527EF4E-EF67-4F97-B647-67B11824F71B wds:Q64106171-2AF5C7AA-DADD-4780-80A9-23367538A9B8 wds:Q64106171-3278BBE8-0EDF-45FF-B09F-979AF1C5E52E wds:Q64106171-3C71A913-AA4B-4DEE-B68D-FA3230727875 wds:Q64106171-456EBAA4-1F3E-4754-A16F-7622B6E61784 wds:Q64106171-476FEEC7-5647-4208-8AB8-ADEC5EEAB29B wds:Q64106171-4A4DF9F6-8A58-42A7-90AB-2657EDC578B5 wds:Q64106171-4C06E15C-96FE-4ACC-9D24-951B70268280 wds:Q64106171-54B260C7-C327-4760-B4BC-1794257C0D64 wds:Q64106171-620255DB-949E-4340-B1A1-EB484F7C14C2 wds:Q64106171-6EE39A86-7D39-4571-9DF1-11218E398234 wds:Q64106171-7C6AB94B-D5DF-44E5-A6F0-571F28DACCE2 wds:Q64106171-8094EC63-DC4B-4A4B-B2E0-22400D209D84 wds:Q64106171-84918796-7BB4-4AF6-B896-46E898883C81 wds:Q64106171-8951C1F1-8A31-4B5C-BDF5-42FC4E81513C wds:Q64106171-8BE4C5C2-BC8F-4971-8F35-B66D76EDB83B wds:Q64106171-9C2B2C8A-A71E-450C-A2FD-1C2E3B2248CF wds:Q64106171-9C521E72-2BD0-4C4C-B061-3DA7BE203845 wds:Q64106171-BA08F360-DCFE-4DEE-AC67-76E05F22B6D3 wds:Q64106171-C2755460-047B-4A24-905D-E8938F6CECDF wds:Q64106171-D07F5337-EAC8-4791-BC1D-A46D370C2A49 wds:Q64106171-D299BEF5-B0A8-48A4-BA8E-3C7BEF22A4C7 wds:Q64106171-D454FDE1-7649-4EFA-AB03-E284C4524029 wds:Q64106171-D694CF2B-2C3C-4136-9E22-1D4E782B7928 wds:Q64106171-E02083D5-9708-4AE4-969C-FBFB112E3DF1 wds:Q64106171-E4634B1A-5563-4DF4-9007-8AFB7E21D06D wds:Q64106171-E896AB30-34F2-49DC-906C-B2AFD38AECB1 wds:Q64106171-E9BACDFD-D90D-4BF3-86A0-CC100794DA8D wds:Q64106171-F527B6FC-4B7D-40FC-AC93-73A049750A11 wds:Q64106171-F6786EA1-7B1C-4174-AA70-ACD2F63DA7B2 wds:Q64106171-FE1EBB40-2EE5-40D3-AF01-59D9DC052742
cites work	To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Rheumatoid arthritis 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers The burden of rheumatoid arthritis and access to treatment: health burden and costs Infliximab treatment maintains employability in patients with early rheumatoid arthritis Work productivity in rheumatoid arthritis: relationship with clinical and radiological features Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study Work disability in rheumatoid arthritis 10 years after the diagnosis Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial Systematic review of studies of productivity loss due to rheumatoid arthritis Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA. The need for standardization: a literature review of indirect costs of rheumatoid arthritis and osteoarthritis Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis Indirect costs of rheumatoid arthritis Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012) Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity. Rheumatoid arthritis: should we shift the focus from "Treat to Target" to "Treat to Work?".
author name string	wds:Q64106171-2031B7A7-D42C-4655-8805-7D6D0AAE3AFF wds:Q64106171-7AF0F41D-B045-48DB-B5C4-F006AF312EC8 wds:Q64106171-95E61CF8-DAF8-41FA-8FA5-CBA8974882B3 wds:Q64106171-C43E6228-6A4B-49E1-A286-A01038B8FCC6 wds:Q64106171-C9826D92-4F1C-40DA-A8AE-B7D5871925A4
author name string	Hani Almoallim Fahdah Alokaily Nahid Janoudi Hanan Alosaimi Zeyad Alzahrani
rdfs:label	Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (en) Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (nl)
skos:prefLabel	Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (en) Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (nl)
name	Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (en) Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (nl)
author	wds:Q64106171-67B54D1D-0933-41AB-86DB-422FA1B1A9CC wds:Q64106171-734FFFC7-9B27-4049-A983-BBD40D243735
author	Suzan Attar Shereen Algohary
title	wds:Q64106171-F7D08EA6-9E6E-4264-AB0A-3B98580DB6DB
title	Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability - Saudi Rheumatoid Arthritis Registry (en)
page(s)	wds:Q64106171-22D23354-AB80-442F-81F7-BF3F029FCB66
page(s)	89-95
instance of	wds:Q64106171-837B4303-CE1A-4EAC-BBF1-219D5697173F
instance of	scholarly article
main subject	wds:Q64106171-421DAB2E-865F-4BAC-9B74-6BB8B8E87B3D wds:Q64106171-D901F897-FDDC-4315-BEB4-CA87233D8128

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software